Trinity Pharmacy, Owner Reach Settlement To Resolve Allegations
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Trinity Pharmacy, Owner Reach Settlement To Resolve Allegations

Trinity Pharmacy, Owner Reach Settlement To Resolve Allegations

February 06, 2017
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Cynthia M. Velazquez
Phone Number: 571-324-7481

Located in Carrollton, Texas: Accused of Failing to Maintain Records, Secure Controlled Substances, File Loss Reports

PLANO, Texas - Trinity Pharmacy in Carrollton, Texas, and one of its owners, Jonathan Paul Lipe, have agreed to pay the United States $400,000 to settle alleged violations of the Controlled Substances Act in the Eastern District of Texas, announced Acting U.S. Attorney Brit Featherston.

The Controlled Substances (CSA) is the primary federal law regulating the distribution and availability of controlled substances.  Strict compliance with the CSA is required in order to prevent, among other things, the unlawful movement of controlled substances into communities. 

Prior to filing a lawsuit, the United States alleged that it had civil penalty claims against both Trinity Pharmacy and Lipe under the CSA for, among other things, failing to maintain required records, failing to secure controlled substances, and failing to file loss reports. According to the settlement agreement, the United States alleged that the CSA violations facilitated and enabled criminal conduct by Trinity Pharmacy’s prior pharmacist-in-charge, John Christopher Esparza.  Esparza misappropriated Trinity Pharmacy’s controlled substances, including 3.1 kilograms of oxycodone powder, and has since plead guilty to Conspiracy to Distribute and Possess with Intent to Distribute a Controlled Substance in violation of the CSA.

Trinity Pharmacy and Lipe agreed to pay $400,000 to resolve the civil allegations and have denied any allegations of wrongdoing.

As the United States Attorney’s Office announced regarding the recent National Prescription Drug Take Back Day, America is presently experiencing an epidemic of addiction, overdose, and death due to abuse of prescription drugs, particularly opioid painkillers. In 2015, approximately 6.4 million Americans aged 12 and over misused prescription drugs, according to the 2015 National Survey on Drug Use and Health-more than those that abused cocaine, heroin, hallucinogens, and methamphetamine combined.  Drug overdoses are now the leading cause of injury-related death in the United States, eclipsing deaths from motor vehicle crashes or firearms.

“Today’s settlement puts on notice every entity and person with obligations under the CSA-including pharmacies and their owners-that the United States will not tolerate carelessness with controlled substances,” said Acting U.S. Attorney Featherston. “Prescription drug abuse is a deadly problem of epidemic proportions in our communities; people are dying every single day because of it.  If you mishandle controlled substances or shirk your obligations under the CSA, expect a visit from us.”

This case was investigated by the Drug Enforcement Administration Dallas Division, the Texas Department of Public Safety, the Texas Board of Pharmacy, the McKinney Police Department, and the U.S. Attorney’s Office for the Eastern District of Texas. The settlement was negotiated by Assistant U.S. Attorney Joshua Russ.  The claims resolved by the settlement are allegations only, and there has been no determination of liability.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Joseph B. Tucker Special Agent in Charge - Dallas
@DEADallasDiv
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster